Voloridge Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,333
Closed -$590K 1615
2020
Q1
$590K Sell
3,333
-94,207
-97% -$17.7M 0.02% 658
2019
Q4
$18.6M Buy
97,540
+93,140
+2,117% +$16.8M 0.36% 52
2019
Q3
$740K Buy
+4,400
New +$717K 0.01% 710
2018
Q1
Sell
-417,401
Closed -$68.3M 710
2017
Q4
$68.3M Buy
+417,401
New +$74.9M 1.49% 9
2016
Q2
Sell
-225,165
Closed -$60.4M 439
2016
Q1
$60.4M Buy
+225,165
New +$64.5M 1.41% 12
2015
Q2
Sell
-127,691
Closed -$38M 409
2015
Q1
$38M Sell
127,691
-129,435
-50% -$36.9M 1.84% 11
2014
Q4
$66.2M Buy
+257,126
New +$64.3M 3.89% 3
2014
Q3
Sell
-26,179
Closed -$5.84M 145
2014
Q2
$5.84M Sell
26,179
-19,282
-42% -$3.99M 0.56% 39
2014
Q1
$9.36M Buy
+45,461
New +$9M 1.33% 23

Other funds holding AGN

Voloridge Investment Management's AGN Position: Q2 2020 in Review

Voloridge Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,333 shares — an estimated $590K sold.

Voloridge Investment Management first reported a position in AGN in Q1 2014 and held it in 9 quarters. The position peaked at $68.3M in Q4 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Voloridge Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 3,333 Allergan plc shares in Q2 2020, an estimated $590K.
  • Voloridge Investment Management first reported a position in Allergan plc in Q1 2014 and held it in 9 quarters.
  • Voloridge Investment Management's Allergan plc position peaked at $68.3M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Voloridge Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.